Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2026-05-16 @ 10:20 AM
Study NCT ID:
NCT00987935
Status:
COMPLETED
Last Update Posted:
2016-03-10
First Post:
2009-09-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Carcinoma, Hepatocellular | View |
Keywords: